These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 24846444)

  • 1. Poor glycemic control and decreased renal function are associated with increased intrarenal RAS activity in Type 2 diabetes mellitus.
    Nakatani S; Ishimura E; Naganuma T; Nakatani A; Ichii M; Fukumoto S; Mori K; Emoto M; Nakatani T; Inaba M
    Diabetes Res Clin Pract; 2014 Jul; 105(1):40-6. PubMed ID: 24846444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased urinary excretion of angiotensinogen is associated with risk of chronic kidney disease.
    Mills KT; Kobori H; Hamm LL; Alper AB; Khan IE; Rahman M; Navar LG; Liu Y; Browne GM; Batuman V; He J; Chen J
    Nephrol Dial Transplant; 2012 Aug; 27(8):3176-81. PubMed ID: 22399491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients.
    Kobori H; Alper AB; Shenava R; Katsurada A; Saito T; Ohashi N; Urushihara M; Miyata K; Satou R; Hamm LL; Navar LG
    Hypertension; 2009 Feb; 53(2):344-50. PubMed ID: 19075095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary angiotensinogen reflects the activity of intrarenal renin-angiotensin system in patients with IgA nephropathy.
    Nishiyama A; Konishi Y; Ohashi N; Morikawa T; Urushihara M; Maeda I; Hamada M; Kishida M; Hitomi H; Shirahashi N; Kobori H; Imanishi M
    Nephrol Dial Transplant; 2011 Jan; 26(1):170-7. PubMed ID: 20615910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ELISA examining urinary angiotensinogen as a potential indicator of intrarenal renin-angiotensin system (RAS) activity: a clinical study of 128 chronic kidney disease patients.
    Zhang XY; Ding XQ; Lv WL; Teng J; Zhong YH
    Mol Biol Rep; 2013 Oct; 40(10):5817-24. PubMed ID: 24065527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronotherapy with a Renin-angiotensin System Inhibitor Ameliorates Renal Damage by Suppressing Intrarenal Renin-angiotensin System Activation.
    Aoki T; Ohashi N; Isobe S; Ishigaki S; Matsuyama T; Sato T; Fujikura T; Kato A; Miyajima H; Yasuda H
    Intern Med; 2020; 59(18):2237-2244. PubMed ID: 32938851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary Angiotensinogen in addition to Imaging Classification in the Prediction of Renal Outcome in Autosomal Dominant Polycystic Kidney Disease.
    Park HC; Kim J; Cho A; Kim DH; Lee YK; Ryu H; Kim H; Oh KH; Oh YK; Hwang YH; Lee KB; Kim SW; Kim YH; Lee J; Ahn C;
    J Korean Med Sci; 2020 Jun; 35(22):e165. PubMed ID: 32508065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in Urinary Angiotensinogen Associated with Deterioration of Kidney Function in Patients with Type 2 Diabetes Mellitus.
    Lee MJ; Kim SS; Kim IJ; Song SH; Kim EH; Seo JY; Kim JH; Kim S; Jeon YK; Kim BH; Kim YK
    J Korean Med Sci; 2017 May; 32(5):782-788. PubMed ID: 28378551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of intrarenal renin-angiotensin system activity in diabetic versus non-diabetic patients with overt proteinuria.
    Park JH; Jang HR; Lee JH; Lee JE; Huh W; Lee KB; Kwon YJ; Do JY; Kim HY; Kim YG
    Nephrology (Carlton); 2015 Apr; 20(4):279-85. PubMed ID: 25522682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Relationship between the Intrarenal Dopamine System and Intrarenal Renin-angiotensin System Depending on the Renal Function.
    Matsuyama T; Ohashi N; Ishigaki S; Isobe S; Tsuji N; Fujikura T; Tsuji T; Kato A; Miyajima H; Yasuda H
    Intern Med; 2018 Nov; 57(22):3241-3247. PubMed ID: 29984779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased heart rate is associated with intrarenal renin-angiotensin system activation in chronic kidney disease patients.
    Ohashi N; Isobe S; Ishigaki S; Aoki T; Matsuyama T; Sato T; Fujikura T; Kato A; Yasuda H
    Clin Exp Nephrol; 2019 Sep; 23(9):1109-1118. PubMed ID: 31131423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrarenal Renin-Angiotensin System Activation Alters Relationship Between Systolic Blood Pressure and Progression of Chronic Kidney Disease.
    Park CH; Kim HW; Park JT; Chang TI; Yoo TH; Lee J; Sung S; Jung JY; Hyun YY; Oh KH; Kang SW; Han SH;
    Hypertension; 2023 May; 80(5):1024-1034. PubMed ID: 37075134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary angiotensinogen as a potential biomarker of intrarenal renin-angiotensin system activity in Chinese chronic kidney disease patients.
    Xu Z; Xu B; Xu C
    Ir J Med Sci; 2015 Jun; 184(2):297-304. PubMed ID: 24664631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased urinary Angiotensinogen/Creatinine (AGT/Cr) ratio may be associated with reduced renal function in autosomal dominant polycystic kidney disease patients.
    Park HC; Kang AY; Jang JY; Kim H; Han M; Oh KH; Kim SH; Noh JW; Cheong HI; Hwang YH; Ahn C
    BMC Nephrol; 2015 Jun; 16():86. PubMed ID: 26092580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction in urinary angiotensinogen levels and improvement of proteinuria by renin-angiotensin system blockade in pediatric chronic kidney disease patients with very low birth weight.
    Yamamura-Miyazaki N; Michigami T; Satomura K; Urushihara M; Kagami S; Yamamoto K
    Pediatr Nephrol; 2020 Jul; 35(7):1307-1314. PubMed ID: 32162100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary angiotensinogen antedates the development of stage 3 CKD in patients with type 1 diabetes mellitus.
    Ba Aqeel S; Ye M; Wysocki J; Sanchez A; Khattab A; Lores E; Rademaker A; Gao X; Bebu I; Nelson RG; Molitch M; Batlle D;
    Physiol Rep; 2019 Oct; 7(19):e14242. PubMed ID: 31605461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D receptor activation with calcitriol for reducing urinary angiotensinogen in patients with type 2 diabetic chronic kidney disease.
    Tiryaki Ö; Usalan C; Sayiner ZA
    Ren Fail; 2016; 38(2):222-7. PubMed ID: 26707134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients.
    Kim SS; Song SH; Kim IJ; Yang JY; Lee JG; Kwak IS; Kim YK
    Diabetes Res Clin Pract; 2012 Aug; 97(2):251-7. PubMed ID: 22440044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased urinary angiotensinogen precedes the onset of albuminuria in normotensive type 2 diabetic patients.
    Zhuang Z; Bai Q; A L; Liang Y; Zheng D; Wang Y
    Int J Clin Exp Pathol; 2015; 8(9):11464-9. PubMed ID: 26617876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of renin-angiotensin system markers in youth with type 2 diabetes and associations with renal outcomes.
    Dart AB; Wicklow B; Scholey J; Sellers EA; Dyck J; Mahmud F; Sochett E; Hamilton J; Blydt-Hansen T; Burns K
    Pediatr Diabetes; 2020 Nov; 21(7):1102-1109. PubMed ID: 32657529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.